У нас вы можете посмотреть бесплатно SightByte News May 2025: Susvimo for DR, Flying Baby in Glaucoma & More! или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
From flying babies to laser-sharp legislation, May's biggest eye care headlines are here—and they're anything but blurry. Here’s what’s crystal clear: Global Vision Crisis Still Uncorrected A new study finds that only 65.5% of people who need glasses have them—with the right Rx. That’s “effective refractive error coverage,” and we’ve barely made progress since 2010. WHO’s ambitious goals for 2030? Still looking a bit out of focus. Read more: https://cookiemagazine.org/global-eye... Flying Babies & Glaucoma Detection? A team in India is making waves with swept-source AS-OCT—possibly diagnosing early childhood glaucoma without anesthesia. Cue the “flying baby” technique. Read more: https://cakemagazine.org/new-swept-so... FDA Approves Susvimo for Diabetic Retinopathy Think of it as a retinal slow-drip: Genentech’s Susvimo implant just got approved for DR, cutting injections down to once every 9 months. Read more: https://piemagazine.org/fda-approves-... West Virginia Optometrists Get the Green Light for Lasers Senate Bill 565 just made WV the 13th U.S. state to allow in-office laser procedures by ODs. It’s not just scope creep—it’s a full-on scope leap. Read more: https://cookiemagazine.org/west-virgi... Subscribe for more bite-sized brilliance from the world of eye care, only on SightByte News by MICE TV. Got a spicy story or a hot take? Drop it in the comments! #MICETV #EyeCare #SightByteNews #mediamice Disclaimer: This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.